Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guglielmo Albertini Petroni

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
SAGE Open Medical Case Reports|April 17, 2023
Efficacy of vedolizumab as maintenance therapy in a patient with ulcerative colitis receiving haemodialysis in end-stage kidney failure: A case reportGuglielmo Albertini Petroni, Laura Francesca Pisani, Edoardo Borsotti, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
Artificial Intelligence in Inflammatory Bowel Disease EndoscopySabrina Gloria Giulia Testoni, Guglielmo Albertini Petroni, Maria Laura Annunziata, et al.
Journal of Personalized Medicine|September 26, 2025
Cardiovascular Complications Are Increased in Inflammatory Bowel Disease: A Path Toward Achievement of a Personalized Risk EstimationVito Annese, Maria Laura Annunziata, Guglielmo Albertini Petroni, et al.
Journal of Clinical Medicine|January 8, 2025
The Role of Therapeutic Endoscopic Ultrasound in Management of Malignant Double Obstruction (Biliary and Gastric Outlet): A Comprehensive Review with Clinical ScenariosGiuseppe Dell'Anna, Rubino Nunziata, Claudia Delogu, et al.
Journal of Clinical Gastroenterology|November 12, 2025
The AFS Endoscopic Classification of Esophago-Gastric Junction Integrity is Superior to the Hill Classification in Terms of Interobserver VariabilityStefano Siboni, Marco Sozzi, Andrea Lovece, et al.
Haematologica|May 30, 2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913Sabina Chiaretti, Monica Messina, Irene Della Starza, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
SAGE Open Medical Case Reports|April 17, 2023
Efficacy of vedolizumab as maintenance therapy in a patient with ulcerative colitis receiving haemodialysis in end-stage kidney failure: A case reportGuglielmo Albertini Petroni, Laura Francesca Pisani, Edoardo Borsotti, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
Artificial Intelligence in Inflammatory Bowel Disease EndoscopySabrina Gloria Giulia Testoni, Guglielmo Albertini Petroni, Maria Laura Annunziata, et al.
Journal of Personalized Medicine|September 26, 2025
Cardiovascular Complications Are Increased in Inflammatory Bowel Disease: A Path Toward Achievement of a Personalized Risk EstimationVito Annese, Maria Laura Annunziata, Guglielmo Albertini Petroni, et al.
Journal of Clinical Medicine|January 8, 2025
The Role of Therapeutic Endoscopic Ultrasound in Management of Malignant Double Obstruction (Biliary and Gastric Outlet): A Comprehensive Review with Clinical ScenariosGiuseppe Dell'Anna, Rubino Nunziata, Claudia Delogu, et al.
Journal of Clinical Gastroenterology|November 12, 2025
The AFS Endoscopic Classification of Esophago-Gastric Junction Integrity is Superior to the Hill Classification in Terms of Interobserver VariabilityStefano Siboni, Marco Sozzi, Andrea Lovece, et al.
Haematologica|May 30, 2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913Sabina Chiaretti, Monica Messina, Irene Della Starza, et al.
Pageof 1